btbr

interleukin 17A ; Mus musculus







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35070938 Metal arsenic mediated enhancement of type-2 immunity in brains with altered locomotive activities in mice with autism-like behavioral characteristics. 2022 Jan 1
2 33671196 5-Aminoisoquinolinone, a PARP-1 Inhibitor, Ameliorates Immune Abnormalities through Upregulation of Anti-Inflammatory and Downregulation of Inflammatory Parameters in T Cells of BTBR Mouse Model of Autism. 2021 Feb 17 1
3 30790585 Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice. 2019 May 17 1
4 30982673 Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy. 2019 Jun 1
5 31522074 The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T+ Itpr3tf/J mice exposed to gamma rays. 2019 Oct 1
6 30172736 Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism. 2018 Sep 1
7 27578011 Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism. 2017 Sep 1